# Eqalix, Inc.: Form D filings

Eqalix, Inc., a biotechnology company in Reston, VA, filed 3 Form D notices with the SEC between 2011 and 2012. The latest, on June 8, 2012, reports an offering of $500,000 with nothing sold yet.

Find out what Eqalix, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Eqalix%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Eqalix%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Feqalix-inc-1528110)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Eqalix%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Eqalix%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Feqalix-inc-1528110)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Virginia](https://specstream.ai/data/form-d/state/virginia): 771 rows, by operating companies, filed since November 1, 2024, $38.55, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/virginia
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1900 CAMPUS COMMONS DRIVE, SUITE 100, Reston, VA, 20191
- Phone: (703) 766-5749
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Virginia
- Year incorporated: 2011
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1528110

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 8, 2012 | Amendment | $500,000 | $0 | $500,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1528110/000152811012000002/0001528110-12-000002-index.htm) |
| Jun 5, 2012 | New notice | $500,000 | $0 | $500,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1528110/000152811012000001/0001528110-12-000001-index.htm) |
| Aug 16, 2011 | New notice | $75,000 | $25,000 | $50,000 | 1 | Aug 5, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1528110/000152811011000001/0001528110-11-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Joseph P Connell | Executive Officer, Director, Promoter |  |
| Reinhard P Koenig, MD | Promoter |  |
| Sven P Rohmann, MD, Phd | Director |  |

## Other biotechnology companies in Virginia that filed recently

- [GENHEALTH, INC.](https://specstream.ai/data/form-d/company/genhealth-inc-1980883) $16.5 million · Sep 29, 2026
- [SalivIQ Diagnostics Inc.](https://specstream.ai/data/form-d/company/saliviq-diagnostics-inc-2138504) $1.9 million · Sep 23, 2026

[Every Form D from the week of Jun 4, 2012](https://specstream.ai/data/form-d/week/2012-06-04) · [All recent filings in Virginia](https://specstream.ai/data/form-d/state/virginia) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Eqalix, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).